We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Expandable Arterial Stent Helps Treat Iliac Stenosis

By HospiMedica International staff writers
Posted on 03 Jun 2014
Print article
Image: The Visi-Pro balloon-expandable stent system (Photo courtesy of Covidien).
Image: The Visi-Pro balloon-expandable stent system (Photo courtesy of Covidien).
A balloon-expandable stent system helps patients regain blood flow by treating lesions of the common and external iliac arteries.

The Visi-Pro balloon-expandable stent system is intended to improve and maintain artery luminal diameter in occlusions or lesions at high risk for abrupt closure following percutaneous transluminal angioplasty (PTA), or in lesions believed to be at high risk of stenosis following PTA in the common and external iliac, subbclavian, and renal arteries. The stent is also indicated for use as a palliative treatment of malignant neoplasms in the biliary tree.

The Visi-Pro is made from a 316L stainless steel tube with a diameter of 0.9 mm cut into an open lattice design; tantalum radiopaque markers are placed at the proximal and distal ends of the stent for guided placement. For delivery, the stent is mounted onto a tightly-folded balloon catheter, and then expanded and deployed by inflating the balloon. Other features include solid radial strength, flexibility, superior trackability, and a unique 5-fold balloon wrap that improves retraction.

In a prospective, multicenter, nonrandomized study that enrolled 75 patients at 17 centers in the United States and Europe, The Visi-Pro met its primary nine month endpoint, with a major adverse event rate of just 4%. Additionally, the technology achieved 100% device success, with primary patency and freedom from clinically-driven target lesion revascularization at nine months at 95.8%. The Visi-Pro is a product of Covidien (Dublin, Ireland), and has received the European Community CE marking of approval.

“The nine month results were positive, demonstrating the effectiveness of the technology in treating patients with iliac disease, regardless of gender, lesion location, or severity,” said lead author John Rundback, MD, of the Holy Name Medical Center (Teaneck, NJ, USA). “A unique benefit of the Visi-Pro stent is its excellent visibility during deployment, which optimizes precise positioning and minimizes the risk of geographic miss that is inherent to iliac stent procedures.”

Related Links:

Covidien
Holy Name Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Ultrasound System
Aplio me

Print article

Channels

Critical Care

view channel
Image: A full readout from the new AI algorithm that helps read EEGs (Photo courtesy of Duke University)

AI Doubles Medical Professionals’ Accuracy in Reading EEG Charts of ICU Patients

Electroencephalography (EEG) readings are crucial for detecting when unconscious patients may be experiencing or are at risk of seizures. EEGs involve placing small sensors on the scalp to measure the... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more